Clinical Efficacy of Polymyxin B in Patients Infected with Carbapenem-Resistant Organisms

PURPOSE: Carbapenem-resistant organisms (CROs) pose great challenges for clinical treatment. Polymyxin B (PMB) is one of the “last resort” choices of CRO infections. We explored the possible factors affecting PMB efficacy. PATIENTS AND METHODS: This retrospective study involved CRO-infected patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Qiong, Li, Guo-Hua, Qu, Qiang, Zhu, Hai-Hong, Luo, Yue, Yan, Han, Yuan, Hai-Yan, Qu, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168961/
https://www.ncbi.nlm.nih.gov/pubmed/34093026
http://dx.doi.org/10.2147/IDR.S312708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168961/
https://www.ncbi.nlm.nih.gov/pubmed/34093026
http://dx.doi.org/10.2147/IDR.S312708

Ejemplares similares